Arax Advisory Partners’s Nuveen AA-BBB CLO ETF NCLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9M Buy
473,007
+112,052
+31% +$2.8M 0.08% 269
2026
Q1
$9M Buy
360,955
+219,472
+155% +$5.48M 0.25% 85
2025
Q4
$3.54M Sell
141,483
-2,244
-2% -$56.2K 0.1% 160
2025
Q3
$3.61M Buy
143,727
+72,537
+102% +$1.82M 0.05% 311
2025
Q2
$1.79M Buy
+71,190
New +$1.78M 0.08% 160

Other funds holding NCLO

Arax Advisory Partners's NCLO Position: Q2 2026 in Review

Arax Advisory Partners increased its Nuveen AA-BBB CLO ETF (NCLO) stake by 31% in Q2 2026, buying an estimated $2.8M and bringing the position to 473,007 shares worth $11.9M. The position accounts for 0.08% of the portfolio, ranked #269.

Arax Advisory Partners first reported a position in NCLO in Q2 2025 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold NCLO as of Q2 2026.

  • Arax Advisory Partners held 473,007 shares of Nuveen AA-BBB CLO ETF worth $11.9M as of Q2 2026.
  • Arax Advisory Partners bought 112,052 Nuveen AA-BBB CLO ETF shares in Q2 2026, an estimated $2.8M.
  • Nuveen AA-BBB CLO ETF made up 0.08% of Arax Advisory Partners's portfolio in Q2 2026, its #269 holding.
  • Arax Advisory Partners first reported a position in Nuveen AA-BBB CLO ETF in Q2 2025 and has held it in 5 quarters since.
  • 13 funds tracked by Wall St. Rank held Nuveen AA-BBB CLO ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.